How many 8-K/A filings has Abvc Biopharma, Inc. filed?

Abvc Biopharma, Inc. (ABVC) has 13 8-K/A (Amended Current Event Report) filings on record, spanning Jan 2024 to Sep 2025.

What is a 8-K/A filing?

A 8-K/A is an SEC filing known as "Amended Current Event Report." It is filed with the SEC as a Amended Current Event Report.

Where can I read Abvc Biopharma, Inc. 8-K/A filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Abvc Biopharma, Inc. 8-K/A filings, including risk assessment, sentiment analysis, and key financial figures.

Abvc Biopharma, Inc. (ABVC) — 8-K/A Filings

All 8-K/A filings from Abvc Biopharma, Inc.. Browse 13 Amended Current Event Report reports with AI-powered summaries and risk analysis.

8-K/A Filings (13)

ABVC Biopharma Files Amendment on Accountant Change — Sep 12, 2025 Risk: low
ABVC Biopharma, Inc. filed an amendment (8-K/A) on September 12, 2025, to a previous report dated October 18, 2024. This amendment pertains to a change in the r
ABVC Biopharma Files 8-K/A Amendment — Jul 18, 2025 Risk: medium
ABVC Biopharma, Inc. filed an amendment (8-K/A) on July 18, 2025, to a previous filing dated February 8, 2024. This amendment pertains to the entry into a mater
ABVC Biopharma Files 8-K/A Amendment — May 30, 2025 Risk: medium
ABVC Biopharma, Inc. filed an 8-K/A on May 30, 2025, to amend a previous filing concerning unregistered sales of equity securities. The amendment relates to eve
ABVC Biopharma Files Amendment on Delisting Concerns — May 14, 2025 Risk: medium
ABVC Biopharma, Inc. filed an amendment (8-K/A) on May 14, 2025, to its previous filings concerning the delisting of its securities. The amendment addresses eve
ABVC Biopharma Files 8-K/A Amendment on Listing Status — May 6, 2025 Risk: medium
ABVC Biopharma, Inc. filed an 8-K/A on May 6, 2025, to amend a previous filing. The amendment concerns the company's notice of delisting or failure to satisfy a
ABVC BioPharma Amends Financial Statement Reliance Filing — May 2, 2025 Risk: medium
ABVC BioPharma, Inc. filed an 8-K/A on May 2, 2025, to amend a previous filing concerning the non-reliance on previously issued financial statements. This amend
ABVC BioPharma Files 8-K Amendment — Apr 16, 2025 Risk: low
ABVC BioPharma, Inc. filed an amendment (8-K/A) on April 16, 2025, to a previous Form 8-K. The amendment pertains to Item 8.01 (Other Events) and Item 9.01 (Fin
ABVC Biopharma Files 8-K/A Amendment on Listing Rule Compliance — Jan 13, 2025 Risk: medium
ABVC Biopharma, Inc. filed an amendment (8-K/A) on January 13, 2025, to a previous report dated July 12, 2024. This amendment concerns a notice of delisting or
ABVC Biopharma Files 8-K/A Amendment — Jun 25, 2024 Risk: low
ABVC Biopharma, Inc. filed an amendment (8-K/A) on June 25, 2024, to a previous Form 8-K dated November 16, 2023. This amendment pertains to the entry into a ma
ABVC Biopharma Files 8-K/A Amendment — Jun 24, 2024 Risk: low
ABVC Biopharma, Inc. filed an amendment (8-K/A) on June 24, 2024, to a previous Form 8-K dated March 26, 2024. This amendment pertains to the entry into a mater
ABVC BioPharma Amends Material Agreement Filing — Feb 29, 2024 Risk: medium
ABVC BIOPHARMA, INC. filed an 8-K/A on February 29, 2024, amending a previous 8-K filing from November 20, 2023. The amendment pertains to an "Entry into a Mate
ABVC BioPharma Amends 8-K for Financial Statement Inclusion — Jan 26, 2024
ABVC BioPharma, Inc. filed an 8-K/A on January 26, 2024, to amend its previous 8-K filing from November 16, 2023. This amendment, labeled "Amendment No. 1," pri
ABVC BioPharma Amends 8-K Filing for Material Agreement — Jan 17, 2024
ABVC BioPharma, Inc. filed an 8-K/A on January 17, 2024, to amend its previous 8-K filing from November 20, 2023. This amendment clarifies information related t

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX